PULMATRIX, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
PULMATRIX, INC. (PULM) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $388.00 thousand for the 12-month period ending 2015-03-31, per its 10-K filed 2015-06-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2015-06-10
- PULMATRIX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2015-03-31 was $61.00K.
- PULMATRIX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-12-31 was $1.00K, a 99.79% decline year-over-year.
- PULMATRIX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-09-30 was $30.00K, a 57.14% decline year-over-year.
- PULMATRIX, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-06-30 was $296.00K, a 20.33% increase year-over-year.
- PULMATRIX, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2015 was $388.00K, a 165.75% increase from fiscal 2014.
- PULMATRIX, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2014 was $146.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2015-03-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $62.00K derived: sum of 2 quarters · filed 2015-06-10 | $92.00K derived: sum of 3 quarters · filed 2015-06-10 | $388.00K 10-K · filed 2015-06-10 |
| 2014-12-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $31.00K derived: sum of 2 quarters · filed 2015-02-13 | $327.00K 10-Q · filed 2015-02-13 | -$326.00K derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-09-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $326.00K 10-Q · filed 2014-11-13 | -$327.00K derived: sum of 3 quarters · filed 2015-06-10 | $156.00K derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-06-30 | $296.00K 10-Q · filed 2014-08-14 | -$357.00K derived: sum of 2 quarters · filed 2015-06-10 | $126.00K derived: sum of 3 quarters · filed 2015-06-10 | $196.00K derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-03-31 | -$653.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | -$170.00K derived: sum of 2 quarters · filed 2015-06-10 | -$100.00K derived: sum of 3 quarters · filed 2015-06-10 | $146.00K 10-K · filed 2015-06-10 |
| 2013-12-31 | $483.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $553.00K derived: sum of 2 quarters · filed 2015-02-13 | $799.00K 10-Q · filed 2015-02-13 | |
| 2013-09-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $316.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $246.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |